Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
97 /100
CRITICAL RISK
Score updated Oct 28, 2026

VBIO — Valion Bio, Inc. Dilution Risk Tracker

Track VBIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VBIO — Get alerts when the score changes →

As of October 28, 2026, Valion Bio, Inc. (VBIO) has a DilutionWatch DilutionScore of 97/100, rated CRITICAL dilution risk. Valion Bio, Inc. has a market capitalization of $17.35M, 22.19M shares outstanding. Stored dilution-related fields include 8.67M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
95
📊 Float Risk
95
⚠️ Warrant Exposure
90
🔄 Convertible Debt
35

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 64%
🔄 Reverse Split model est. 70%
• 50-day avg $0.99 below $1 exchange minimum
• Only 2 months cash — financial pressure
📜 Warrant Exercise model 60%
• Massive warrant overhang: 39% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise model 55%
• Critical: only 2.5 months cash remaining
🔔 Track VBIO — Get forecast alerts →

Market Data

Market Cap$17.35M
Shares Outstanding22.19M
Float2.76M
Cash$2.11M
Debt$6.45M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore97/100DilutionWatch score record
Shares Outstanding22.19MVerified float table or market cache
Public Float2.76MVerified float table or market cache
Market Cap$17.35MMarket data cache
Cash Runway2.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants8.67MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 8-K 1, SC 13D/A 4, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

VBIO SEC Filing Activity — Last 12 Months

Shares outstanding reported by VBIO on the cover page of its latest 10-K/10-Q: 22.19M as of August 13, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for VBIO in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)1Jul 14, 2026
SC 13Dactivist / >5% holder filing1Aug 03, 2026
3initial insider ownership1Jul 17, 2026

Institutional Holdings

10.5% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track VBIO for full holder detail →

Short Interest

Short Interest115.5K
Days to Cover1.0
% of Float4.2%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-14
xbrl XBRL CONVERTIBLE 2023-03-31
SC 13D/A BENEFICIAL OWNERSHIP 2026-08-27
SC 13D/A BENEFICIAL OWNERSHIP 2026-08-24
SC 13D/A BENEFICIAL OWNERSHIP 2026-08-19
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual VBIO Dilution Snapshot

Valion Bio, Inc. (VBIO) has a DilutionScore of 97/100, rated Critical dilution risk. Score date: October 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

VBIO's DilutionScore is currently 97/100 (Critical risk), with 5 score changes tracked over 89 days. The score improved from 96/100 (Critical risk).

Period Score Risk Level Duration
Oct 14 – Oct 28, 202697/100CRITICAL15 days
Oct 09 – Oct 13, 202696/100CRITICAL5 days
Sep 28 – Oct 08, 2026100/100CRITICAL11 days
Aug 22 – Sep 27, 202693/100CRITICAL37 days
Aug 14 – Aug 21, 202669/100HIGH7 days
Jul 31 – Aug 13, 202674/100HIGH14 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

VBIO shares outstanding have decreased 0.0% from 3.14M (May 2026) to 3.14M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 16, 20263.14M2.76M▲ 0.40%
May 11, 20263.14M2.75M▲ 9.11%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track VBIO Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment VBIO files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking VBIO — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,567+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations